DHR Danaher Corporation
XNYS
230.42
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
DHR
$230.42
—
Key stats
$230.42
- 52-Week Range
- $160.93 – $242.80
- YTD
- +0.01%
- IV Rank (30D)
- 24.03
- Straddle Price
- $16.15
- P/C Vol Ratio
- 0.93
- Market Cap
- $161.5B
- Open
- $229.17
- Day Range
- $225.60 – $230.66
- Volume
- 3,935,939
- Prev Close
- $229.75
Fair Value
MODEL: NEUTRAL
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.12% |
| Beta vs SPY | 0.94 |
| Cost of Equity (CAPM) | 9.84% (VRP-adj) |
| WACC | 9.32% |
| Volatility Risk Premium | +17.3pp (IV − HV30) |
| Effective Tax Rate | 11.0% |
| Rev. Growth (YoY, DCF input) | -4.2% |
| DCF Horizon | 12 years explicit + fade |
| Free Cash Flow (TTM) | $5.7B |
| Return on Equity (TTM) | 8.1% |
| Book / Price | 32.9% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 58.6% |
| FCF Margin (TTM) | 22.4% |
| Debt / Equity | 0.45 |
| Quality Score | 4/6 — high quality (12y DCF) |
| Market-Implied Growth | +14.2% (reverse-DCF on current price) |
| SMA 50 | $215.60 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $222.97 |
| Bollinger Width / SMA20 | 4.6% (drives anchor stability) |
| Net Debt | $18.7B |
| Market Cap | $163B |
Peers used for multiples: FTV, MKSI, RAL, ROP, SENS, ST, SYPR
(SIC-code peers; ETF co-membership was sector-incoherent)
60-Day Conviction
24%
20-Day Fair Value
≈ by Nov 23, 2026
$231.44
α +0.4%
rank 10%
conviction
27%
40-Day Fair Value
≈ by Dec 22, 2026
$233.23
α +1.2%
rank 10%
conviction
38%
60-Day Fair Value
≈ by Jan 20, 2027
$229.04
α -0.6%
rank 10%
conviction
24%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $53.31 | 19% | |
| DDM (Gordon) | $10.41 | 0% | |
| Peer P/E | $202.70 | 6% | median 33.2× · 4 peers |
| Peer EV/EBITDA | $169.41 | 6% | median 17.7× · 5 peers |
| Peer P/B | $267.75 | 6% | median 3.5× · 7 peers |
| Peer P/S | $126.76 | 6% | median 3.5× · 7 peers |
| Market Anchor (SMA50) | $215.60 | 38% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | $231.71 | 19% | 35 strikes · skew +0.82 |
As of 2026-10-23 · updated
Related
About
- Industry (SIC)
- INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL (3823) · industry map
- Exchange
- XNYS
- Market Cap
- $161.5B
- Employees
- 60,000
- List Date
- 1978-12-29
- CIK
- 0000313616
- Headquarters
- Washington, DC
- Homepage
- https://www.danaher.com
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 6.54% | -9.49% | 0.80% | 2.18% | -3.08% | -5.00% | -1.34% |
| Feb | -9.13% | -4.48% | -7.47% | 3.27% | -3.03% | -5.72% | -4.43% |
| Mar | -0.26% | 7.83% | 2.72% | -2.40% | -0.34% | -7.96% | -0.07% |
| Apr | 12.82% | -13.91% | -5.27% | -0.47% | -0.53% | -6.21% | -2.26% |
| May | 0.58% | 5.31% | -5.01% | 4.01% | -3.46% | 4.29% | 0.95% |
| Jun | 9.44% | -2.87% | 3.14% | -4.41% | 4.39% | 5.90% | 2.60% |
| Jul | 9.29% | 12.95% | 7.71% | 13.32% | -1.96% | 0.76% | 7.01% |
| Aug | 9.13% | -6.25% | 3.92% | -4.08% | 4.43% | 8.13% | 2.55% |
| Sep | -7.07% | -5.69% | -6.59% | 5.22% | -2.71% | 7.07% | -1.63% |
| Oct | 3.13% | -6.37% | -10.16% | -10.53% | 1.17% | 8.85%* | -2.32% |
| Nov | 3.86% | 6.88% | 17.53% | -3.26% | 5.94% | -- | 6.19% |
| Dec | 2.91% | -3.32% | 3.52% | -4.87% | 2.13% | -- | 0.07% |
| Total | 46.50% | -20.68% | 1.62% | -4.03% | 2.37% | 8.43% | 5.70% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $223.27
SMA 50: $216.13
SMA 200: $201.20
Current: $230.50
EMA 12: $226.44
EMA 26: $222.15
MACD: 4.2860 | Signal: 0.4942
BULLISH
ADX (14): 31.37
TREND
+DI: 28.83
−DI: 14.16
Momentum Oscillators
RSI (14): 59.86
NEUTRAL
Stoch %K: 79.01
Stoch %D: 75.65
Williams %R: -28.88
Volume & Volatility
BB Upper: $235.04
BB Lower: $211.50
NEUTRAL
OBV: -16,660,658
Vol SMA 20: 4,891,376
Vol ROC: 0.04%
ATR: $6.92
True Range: $5.06
HV 20: 33.5%
HV 30: 30.1%
HV 60: 29.0%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-25T00:00:00 – 2026-10-23T00:00:00
AI Analysis
LLM Stock Analysis Report
Executive Summary Overall Assessment: NEUTRAL (Confidence Level: 7/10)
Key Drivers:
- Strong technical signals, including MACD bull signal
- Positive news sentiment from recent headlines
- Low volatility, indicating a stable market regime
Primary Risks:
- High valuation multiples may lead to potential correction
- Diversification concerns due to sector concentration
Investment Thesis: DHR is poised for a moderate upside move as technical indicators align with positive news sentiment. However, the high valuation multiples and sector concentration may limit its growth potential.
Recent News Sentiment Impact: The recent headlines have been overwhelmingly positive, highlighting the company's growth prospects in the life sciences industry. This sentiment has contributed to the stock's upward momentum, making it more likely for DHR to continue its uptrend.
Technical Analysis
Trend Direction: Short-term (1-4 weeks) - Uptrend; Medium-term (1-3 months) - Bullish
Support/Resistance Levels:
- Lower Bollinger Band: $191.52
- Middle Line: $206.56
- Upper Bollinger Band: $221.60
Momentum Signals:
- RSI Interpretation: Neutral (63.25)
- MACD Signal: Bullish
- Bollinger Bands Position: Neutral (squeeze)
Volume Analysis:
- Volume SMA 20: 3424408.91
- On-Balance Volume (OBV): -34098869.53
News & Sentiment Analysis
Recent Headlines Summary: The recent headlines have been overwhelmingly positive, highlighting the company's growth prospects in the life sciences industry.
Sentiment Assessment: Positive
Catalyst Identification:
- Upcoming earnings report
- Regulatory approvals for new products
Market Narrative: The news sentiment aligns with the technical signals, indicating a strong upward momentum. However, there may be some cautionary signs due to the high valuation multiples and sector concentration.
Risk & Volatility Assessment
Beta Interpretation: Low (0.39) - risk relative to market is low
Volatility Regime: Low volatility regime
Options Market Signals:
- IV Rank: 52.5% (Medium)
- Put/Call Volume Ratio: 0.18 (Bullish sentiment)
Downside Protection:
- Support levels at $191.52 and $206.56
- Risk management considerations: position sizing and stop-loss levels
Market Context & Positioning
Sector Performance:
- Life sciences industry is performing well, with a high correlation to the overall market.
Institutional Activity:
- Volume patterns suggest institutional interest in DHR.
Correlation Analysis:
- High correlation (0.16) to the overall market.
Relative Valuation:
- Within trading range, indicating potential for further upside
Key Levels & Action Items
Critical Price Levels:
- Support at $206.56 and $191.52
- Resistance at $221.60
Breakout/Breakdown Levels:
- Critical levels for a breakout: $230.00; critical levels for a breakdown: $190.00
Time-Sensitive Catalysts:
- Earnings report (no specific date available)
- Regulatory approvals for new products
Risk Management:
- Position sizing considerations: 2-3% of portfolio
- Stop-loss levels: below $206.56 or above $221.60
Generated
News
All DHR news →
The conglomerate posted its latest set of quarterly earnings that morning.
Portfolio reshaping complete, management now pivots to organic growth and disciplined acquisitions to compound returns.
Revenue beat $6.6B with 8.5% growth; free cash flow hit $1.6B for the quarter.
Showing 1–10 of 17
Page 1 of 2
Earnings History
16 of 24 under expected move
Avg Expected Move
4.86%
Avg Actual Move
4.10%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-01-13 | Pre-Market | 2.69% | 0.35% | 0.13x | Within |
| 2021-04-22 | Pre-Market | 5.93% | 3.49% | 0.59x | Within |
| 2021-07-22 | Pre-Market | 5.68% | 3.27% | 0.58x | Within |
| 2021-10-21 | Pre-Market | 3.02% | 1.30% | 0.43x | Within |
| 2022-01-11 | Pre-Market | 3.80% | 0.76% | 0.20x | Within |
| 2022-04-21 | Pre-Market | 3.86% | 0.76% | 0.20x | Within |
| 2022-07-21 | Pre-Market | 4.17% | 9.07% | 2.18x | Exceeded |
| 2022-10-20 | Pre-Market | 4.65% | 5.74% | 1.23x | Exceeded |
| 2023-01-09 | Pre-Market | 3.87% | 1.01% | 0.26x | Within |
| 2023-04-25 | Pre-Market | 3.68% | 8.79% | 2.39x | Exceeded |
| 2023-07-25 | Pre-Market | 4.94% | 0.88% | 0.18x | Within |
| 2023-10-24 | Pre-Market | 4.41% | 3.53% | 0.80x | Within |
| 2024-01-08 | Pre-Market | 3.24% | 1.98% | 0.61x | Within |
| 2024-04-23 | Pre-Market | 4.30% | 7.21% | 1.68x | Exceeded |
| 2024-07-23 | Pre-Market | 4.98% | 5.30% | 1.06x | Exceeded |
| 2024-10-22 | Pre-Market | 4.94% | 3.97% | 0.80x | Within |
| 2025-01-29 | Pre-Market | 4.56% | 9.73% | 2.13x | Exceeded |
| 2025-04-22 | Pre-Market | 7.30% | 3.84% | 0.53x | Within |
| 2025-07-22 | Pre-Market | 5.58% | 0.98% | 0.18x | Within |
| 2025-10-21 | Pre-Market | 6.62% | 5.94% | 0.90x | Within |
| 2026-01-28 | Pre-Market | 4.73% | 4.76% | 1.01x | Exceeded |
| 2026-04-21 | Pre-Market | 5.32% | 0.49% | 0.09x | Within |
| 2026-07-21 | Pre-Market | 7.01% | 10.99% | 1.57x | Exceeded |
| 2026-10-21 | Pre-Market | 7.36% | 4.29% | 0.58x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
DHR Options Activity & IV Rank
DHR IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 31.4%
7-DTE IV: 32.1%
Expected Move: $16.15
7-DTE Move: $8.22
Days to Exp: 28 (2026-11-20)
Options Flow
Call Volume: 520
Put Volume: 482
P/C Volume: 0.927
NEUTRAL
Call OI: 6,156
Put OI: 7,097
P/C OI: 1.153
Total OI: 13,253
ATM Options Pricing
ATM Call: $8.40
ATM Put: $7.75
Call %: 3.6%
Put %: 3.4%
Chain Summary
Chain Volume: 9,232
Chain OI: 87,702
Last Updated: 10/23/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
HIGH γ vs HISTORY
Estimated net dealer gamma is at the 86th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
86%
vs own history
GEX tilt
+0.53
OI-weighted, today
Vanna tilt
+0.56
δ-sensitivity to IV
Charm tilt
-0.67
δ-decay vs time
Vanna tilt +0.56: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.67: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 116 ATM contracts, 46k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
99%
+17.8
pts
EXTREME
ATM 32.8% / Wing 50.6%
30 DTE / 10d
8%
+1.0
pts
EXTREME
ATM 31.7% / Wing 32.7%
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)17.0LowOct 23
IV Rank (30 DTE)24.0LowOct 23
Straddle Price (30 DTE)$16.15Oct 23
Beta Analysis
Risk Metrics
Beta: 0.4312
Alpha: 2.31%
Correlation: 0.1823
R-Squared: 3.3%
Stock Volatility: 30.2%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own DHR
11 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $407.7M | #36 of 3716 | +1070.8% | 13F | |
| Glenview Capital Hedge fund Larry Robbins | $218.3M | #7 of 42 | +633.3% | 13F | |
| Citadel Hedge fund Ken Griffin | $179.8M | #221 of 6285 | -8.1% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $144.9M | #97 of 3138 | +12.1% | 13F | |
| Third Point Activist Dan Loeb | $102.9M | #20 of 43 | +2.9% | 13F | |
| Tiger Global Hedge fund Chase Coleman | $86.9M | #32 of 46 | new | 13F | |
| Gates Foundation Trust Foundation Bill Gates | $71.0M | #20 of 24 | 0.0% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $62.9M | #194 of 4729 | -7.2% | 13F | |
| Duquesne Family Office Family office Stanley Druckenmiller | $9.6M | #69 of 86 | new | 13F | |
| Bridgewater Associates Hedge fund Ray Dalio | $4.9M | #489 of 997 | +1.3% | 13F | |
| Point72 Hedge fund Steve Cohen | $2.2M | #1248 of 1945 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
DHR Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 709,100,000 (as of 2026-09-25)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
46 filers$877.71M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $174.80M | 19.92% | 2026-06-30 |
| 2 | Jane Street Group, LLC Custodian | $157.47M | 17.94% | 2026-06-30 |
| 3 | Citadel Advisors LLC Custodian | $98.38M | 11.21% | 2026-06-30 |
| 4 | Holocene Advisors, LP | $92.86M | 10.58% | 2026-06-30 |
| 5 | Oribel Capital Management, LP | $51.14M | 5.83% | 2026-06-30 |
| 6 | IMC-Chicago, LLC Custodian | $45.58M | 5.19% | 2026-06-30 |
| 7 | RIPOSTE CAPITAL LLC | $38.10M | 4.34% | 2026-06-30 |
| 8 | Wolverine Trading, LLC Custodian | $34.90M | 3.98% | 2025-09-30 |
| 9 | Millennium Management LLC Custodian | $34.25M | 3.90% | 2026-06-30 |
| 10 | JPMorgan Chase & Co Custodian | $18.95M | 2.16% | 2026-06-30 |
| 11 | Squarepoint Ops LLC | $13.56M | 1.55% | 2026-06-30 |
| 12 | Simplex Trading, LLC Custodian | $13.05M | 1.49% | 2026-06-30 |
| 13 | Walleye Capital LLC | $10.78M | 1.23% | 2026-06-30 |
| 14 | GROUP ONE TRADING LLC Custodian | $9.62M | 1.10% | 2026-06-30 |
| 15 | Allianz Asset Management GmbH | $8.65M | 0.99% | 2026-06-30 |
| 16 | Maven Securities LTD | $8.14M | 0.93% | 2026-06-30 |
| 17 | Eisler Capital Management Ltd. | $6.24M | 0.71% | 2025-09-30 |
| 18 | UBS Group AG Custodian | $5.50M | 0.63% | 2026-06-30 |
| 19 | BOOTHBAY FUND MANAGEMENT, LLC | $5.26M | 0.60% | 2026-06-30 |
| 20 | D. E. Shaw & Co., Inc. Custodian | $4.61M | 0.53% | 2026-06-30 |
| 21 | Twin Tree Management, LP | $4.44M | 0.51% | 2026-06-30 |
| 22 | TUDOR INVESTMENT CORP ET AL | $3.96M | 0.45% | 2026-06-30 |
| 23 | Walleye Trading LLC | $3.79M | 0.43% | 2026-06-30 |
| 24 | Parallax Volatility Advisers, L.P. | $3.33M | 0.38% | 2026-06-30 |
| 25 | Limestone Investment Advisors LP | $3.05M | 0.35% | 2026-06-30 |
37 filers$557.63M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $152.67M | 27.38% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $92.97M | 16.67% | 2026-06-30 |
| 3 | Jane Street Group, LLC Custodian | $91.09M | 16.33% | 2026-06-30 |
| 4 | Millennium Management LLC Custodian | $31.49M | 5.65% | 2026-06-30 |
| 5 | IMC-Chicago, LLC Custodian | $30.50M | 5.47% | 2026-06-30 |
| 6 | Wolverine Trading, LLC Custodian | $18.64M | 3.34% | 2025-09-30 |
| 7 | Walleye Trading LLC | $14.61M | 2.62% | 2026-06-30 |
| 8 | UBS Group AG Custodian | $14.55M | 2.61% | 2026-06-30 |
| 9 | Allianz Asset Management GmbH | $12.53M | 2.25% | 2026-06-30 |
| 10 | Simplex Trading, LLC Custodian | $12.31M | 2.21% | 2026-06-30 |
| 11 | Goldman Sachs Group Inc Custodian | $10.46M | 1.88% | 2026-06-30 |
| 12 | Walleye Capital LLC | $9.37M | 1.68% | 2026-06-30 |
| 13 | Qube Research & Technologies Ltd | $9.31M | 1.67% | 2026-06-30 |
| 14 | Eisler Capital Management Ltd. | $9.18M | 1.65% | 2025-09-30 |
| 15 | Citigroup Inc. Custodian | $7.62M | 1.37% | 2026-06-30 |
| 16 | CAPSTONE INVESTMENT ADVISORS, LLC | $6.29M | 1.13% | 2026-06-30 |
| 17 | Cubist Systematic Strategies, LLC | $5.87M | 1.05% | 2025-09-30 |
| 18 | Trexquant Investment LP | $4.95M | 0.89% | 2026-06-30 |
| 19 | HBK INVESTMENTS L P | $4.74M | 0.85% | 2026-06-30 |
| 20 | Squarepoint Ops LLC | $2.69M | 0.48% | 2026-06-30 |
| 21 | GROUP ONE TRADING LLC Custodian | $2.46M | 0.44% | 2026-06-30 |
| 22 | Limestone Investment Advisors LP | $2.44M | 0.44% | 2026-06-30 |
| 23 | BNP Paribas Financial Markets Custodian | $1.79M | 0.32% | 2026-06-30 |
| 24 | Point72 Asset Management, L.P. | $1.73M | 0.31% | 2026-06-30 |
| 25 | PEAK6 LLC | $1.60M | 0.29% | 2026-06-30 |
DHR Insider Trading (Form 4)
Latest: 2026-10-14Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | Mitchell P Rales | Chairman of Exec. Committee | Disp (D) | −500,000 | — | EDGAR | |
| 2026-10-14 | Steven M Rales | Chairman | Disp (D) | −500,000 | — | EDGAR | |
| 2026-08-24 | Rainer Blair | President & CEO | Sell (S) | −58,255 | $218.63 | -$12.74M | EDGAR |
| 2026-08-06 | Christopher Paul Riley | Executive Vice President | Award (A) | +41,072 | — | EDGAR | |
| 2026-08-06 | Jonathan Leiken | SVP-Chief Legal Officer | Grant (A) | +92,138 opt | — | EDGAR | |
| 2026-08-06 | Montgomery Julie A Sawyer | Executive Vice President | Grant (A) | +245,701 opt | — | EDGAR | |
| 2026-08-06 | Steven M Rales | Chairman | Award (A) | +500,000 | — | EDGAR | |
| 2026-08-06 | Gregory M Milosevich | Executive Vice President | Award (A) | +15,402 | — | EDGAR | |
| 2026-08-06 | Christopher Bouda | VP, Chief Accounting Officer | Grant (A) | +12,286 opt | — | EDGAR | |
| 2026-08-06 | Jose-Carlos Gutierrez-Ramos | SVP, Chief Science Officer | Award (A) | +13,477 | — | EDGAR | |
| 2026-08-06 | Matthew E Gugino | EVP & Chief Financial Officer | Grant (A) | +153,563 opt | — | EDGAR | |
| 2026-08-06 | Mitchell P Rales | Chairman of Exec. Committee | Award (A) | +500,000 | — | EDGAR | |
| 2026-08-06 | Jonathan Leiken | SVP-Chief Legal Officer | Grant (A) | +92,138 opt | — | EDGAR | |
| 2026-08-06 | Matthew E Gugino | EVP & Chief Financial Officer | Grant (A) | +153,563 opt | — | EDGAR | |
| 2026-08-06 | Jose-Carlos Gutierrez-Ramos | SVP, Chief Science Officer | Award (A) | +13,477 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
DHR Insider Holdings
26 insiders · @ $230.50
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Steven M Rales | Chairman | 34,105,808 | $7.86B | -$245.92M | 10 | 2026-10-14 |
| 2 | Mitchell P Rales | Chairman of Exec. Committee | 26,224,228 | $6.04B | -$581.05M | 31 | 2026-10-14 |
| 3 | Alan G Spoon | Director | 133,473 | $30.77M | -$1.22M | 61 | 2026-08-04 |
| 4 | Rainer Blair | President & CEO | 84,936 | $19.58M | -$58.47M | 54 | 2026-08-24 |
| 5 | Christopher Paul Riley | Executive Vice President | 61,472 | $14.17M | -$3.13M | 15 | 2026-08-06 |
| 6 | John T Schwieters | Director | 57,269 | $13.20M | -$4.95M | 20 | 2025-07-16 |
| 7 | Elias A. Zerhouni | Director | 52,803 | $12.17M | -$3.20M | 61 | 2026-08-04 |
| 8 | Linda Filler | Director | 48,419 | $11.16M | -$10.75M | 64 | 2026-08-04 |
| 9 | Matthew McGrew | Executive Vice President | 37,063 | $8.54M | -$35.71M | 37 | 2026-03-03 |
| 10 | Jose-Carlos Gutierrez-Ramos | SVP, Chief Science Officer | 32,495 | $7.49M | -$268.9K | 24 | 2026-08-06 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
DHR Board & Officers
As of SEC filings through Oct 16, 2026Directors 13
- Mitchell P Rales · on file since Apr 2006
- Alan G Spoon · on file since Jul 2006
- Linda Filler · on file since Jul 2006
- Steven M Rales · on file since Oct 2006
- Elias A. Zerhouni · since Dec 8, 2009
- Teri List · since Sep 13, 2011
- Raymond C Stevens · since Feb 21, 2017
- Rainer Blair · listed since Nov 2020
- A Shane Sanders · since May 12, 2021
- Feroz Dewan · since Jun 27, 2022
- Charles W Lamanna · since Feb 20, 2025
- Robert Hershberg · since Oct 9, 2026
- Daniel L Comas · listed since Oct 2026
Officers 16
- Rainer Blair · President & CEO · listed since Nov 2020
- Brian W Ellis · Senior Vice President - GC · listed since Feb 2021
- Christopher Paul Riley · Executive Vice President · since Jan 1, 2024
- Montgomery Julie A Sawyer · Executive Vice President · since Jul 1, 2024
- Gregory M Milosevich · Executive Vice President · since Jul 1, 2025
- Matthew McGrew · EVP & Chief Financial Officer · since Jan 1, 2019
- Matthew E Gugino · EVP & Chief Financial Officer · since Feb 28, 2026
- Christopher Bouda · VP, Chief Accounting Officer · since Jan 1, 2022
- Jose-Carlos Gutierrez-Ramos · SVP, Chief Science Officer · listed since Feb 2022
- Jonathan Leiken · SVP-Chief Legal Officer · listed since Feb 2026
- Heathre T Moler · SVP, Chief HR Officer · since Oct 1, 2026
- Shashanka Muppaneni · SVP, Chief Strategy Officer · since Oct 1, 2026
- Mitchell P Rales · Chairman of Exec. Committee · on file since Apr 2006
- Steven M Rales · Chairman · on file since Oct 2006
- Georgeann Couchara · SVP, Human Resources · since Apr 1, 2022
- R Bradley Gray · SVP Strategic Development · since Sep 26, 2024
Changes in the last 10 years (41)
| Oct 16, 2026 | Daniel L Comas first listed as a director in an SEC filing |
| Oct 9, 2026 | Robert Hershberg became a director |
| Oct 1, 2026 | Shashanka Muppaneni became SVP, Chief Strategy Officer |
| Oct 1, 2026 | Heathre T Moler became SVP, Chief HR Officer |
| Feb 28, 2026 | Matthew E Gugino became EVP & Chief Financial Officer |
| Feb 5, 2026 | The company announced the departure of Jessica L Mega from the board in an SEC filing |
| Feb 4, 2026 | Jonathan Leiken listed as SVP-Chief Legal Officer (previously SVP- General Counsel) in SEC filings |
| Nov 6, 2025 | The company announced the departure of John T Schwieters from the board in an SEC filing |
| Aug 25, 2025 | Jonathan Leiken became SVP- General Counsel |
| Jul 1, 2025 | Gregory M Milosevich became Executive Vice President |
| Feb 20, 2025 | Charles W Lamanna became a director |
| Dec 9, 2024 | The company announced the departure of Pardis C Sabeti from the board in an SEC filing |
| Sep 26, 2024 | R Bradley Gray became SVP Strategic Development |
| Jul 1, 2024 | Montgomery Julie A Sawyer became Executive Vice President |
| Jun 16, 2024 | The company announced the departure of Joakim Weidemanis as Executive Vice President in an SEC filing |
| Feb 12, 2024 | The company announced the departure of Walter G Lohr from the board in an SEC filing |
| Jan 1, 2024 | Christopher Paul Riley became Executive Vice President |
| Sep 29, 2023 | The company announced the departure of Jennifer Honeycutt as Executive Vice President in an SEC filing |
| Jun 27, 2022 | Feroz Dewan became a director |
| Apr 1, 2022 | The company announced the departure of Angela S Lalor as SVP, Human Resources in an SEC filing |
| Apr 1, 2022 | Georgeann Couchara became SVP, Human Resources |
| Feb 2, 2022 | Jose-Carlos Gutierrez-Ramos listed as SVP, Chief Science Officer (previously SVP, Chief Scientific Officer) in SEC filings |
| Jan 31, 2022 | Robert S Lutz reported in an SEC filing no longer being SVP-Chief Accounting Officer |
| Jan 1, 2022 | Christopher Bouda became VP, Chief Accounting Officer |
| May 12, 2021 | A Shane Sanders became a director |
| Feb 2, 2021 | Brian W Ellis listed as Senior Vice President - GC (previously SVP, GC & Cco) in SEC filings |
| Jan 1, 2021 | Jennifer Honeycutt became Executive Vice President |
| Dec 21, 2020 | Jose-Carlos Gutierrez-Ramos became SVP, Chief Scientific Officer |
| Nov 17, 2020 | Rainer Blair listed as President & CEO (previously Executive Vice President) in SEC filings |
| Nov 17, 2020 | Rainer Blair first listed as a director in an SEC filing |
| Feb 24, 2020 | Brian W Ellis listed as SVP, GC & Cco (previously Senior Vice President - GC) in SEC filings |
| Nov 13, 2019 | Pardis C Sabeti became a director |
| Nov 13, 2019 | Jessica L Mega became a director |
| Feb 4, 2019 | William King listed as SVP, Strategic Development (previously Senior Vice President) in SEC filings |
| Jan 29, 2019 | Daniel L Comas listed as EVP (previously EVP & CFO) in SEC filings |
| Jan 1, 2019 | Matthew McGrew became EVP & Chief Financial Officer |
| May 9, 2018 | William King listed as Senior Vice President (previously SVP, Strategic Development) in SEC filings |
| Feb 22, 2018 | William King listed as SVP, Strategic Development (previously Senior Vice President) in SEC filings |
| Nov 28, 2017 | Joakim Weidemanis became Executive Vice President |
| Feb 21, 2017 | Raymond C Stevens became a director |
| Jan 1, 2017 | Rainer Blair became Executive Vice President |
Not reported recently (6)
- Daniel Raskas · Last reported as SVP-Corporate Development in an SEC filing dated Feb 4, 2025
- William King · Last reported as SVP, Strategic Development in an SEC filing dated May 17, 2024
- Thomas Patrick Joyce JR · Last reported as President and CEO in an SEC filing dated Jul 28, 2020
- William K Daniel · Last reported as EVP in an SEC filing dated Mar 12, 2020
- Donald J Ehrlich · Last reported as a director in an SEC filing dated Feb 11, 2020
- Robert J Hugin · Last reported as a director in an SEC filing dated May 17, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
DHR Proposed Insider Sales (Form 144)
Latest: 2026-08-21
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
1 filing
· $12.7M notice value
· 1 unique filer
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
Top 90-day filers:
Rainer M. Blair (1, $12.7M)
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-08-21 | Rainer M. Blair | Officer | 58,255 | $12.75M | 2026-08-21 | Goldman Sachs & Co. LLC | — | EDGAR |
| 2026-07-14 | SCHWIETERS JOHN T | Former Director | 3,298 | $658.3K | 2026-07-14 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-05-01 | SPOON ALAN G | Director | 1,358 | $237.2K | 2026-05-01 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-02-19 | Milosevich Gregory M | Officer | 1,320 | $274.6K | 2026-02-19 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-11-25 | The Mitchell P. Rales Family Trust | See Remarks | 40,625 | $9.22M | 2025-11-25 | Monness, Crespi, Hardt & Co., In… | — | EDGAR |
| 2025-11-25 | Glenstone Foundation | See Remarks | 146,957 | $33.36M | 2025-11-25 | Monness, Crespi, Hardt & Co., In… | — | EDGAR |
| 2025-11-18 | List Teri | Director | 3,298 | $747.0K | 2025-11-18 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-11-12 | Ellis Brian W | Officer | 21,776 | $4.77M | 2025-11-12 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-11-12 | McGrew Matthew | Officer | 16,172 | $3.47M | 2025-11-11 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-11-12 | Mitchell P. Rales | Dir; Chmn. of Exec. Comm. | 437,000 | $91.74M | 2025-11-12 | Monness, Crespi, Hardt & Co., In… | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-06-03
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Accession | Link |
|---|---|---|
| 2026-06-03 | 0001193125-26-255555 | EDGAR |
| 2026-05-07 | 0000313616-26-000127 | EDGAR |
| 2026-04-29 | 0001193125-26-191608 | EDGAR |
| 2026-04-21 | 0000313616-26-000109 | EDGAR |
| 2026-04-17 | 0001193125-26-160383 | EDGAR |
| 2026-02-17 | 0001193125-26-053124 | EDGAR |
| 2026-02-10 | 0000313616-26-000058 | EDGAR |
| 2026-01-28 | 0000313616-26-000004 | EDGAR |
| 2026-01-12 | 0000313616-26-000002 | EDGAR |
| 2025-11-06 | 0000313616-25-000198 | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-04-21 | 0000313616-26-000107 | EDGAR |
| 2025-10-21 | 0000313616-25-000182 | EDGAR |
| 2025-07-22 | 0000313616-25-000153 | EDGAR |
| 2025-04-22 | 0000313616-25-000088 | EDGAR |
| 2024-10-22 | 0000313616-24-000220 | EDGAR |
| 2024-07-23 | 0000313616-24-000186 | EDGAR |
| 2024-04-23 | 0000313616-24-000102 | EDGAR |
| 2023-10-24 | 0000313616-23-000256 | EDGAR |
| 2023-07-25 | 0000313616-23-000214 | EDGAR |
| 2023-04-25 | 0000313616-23-000125 | EDGAR |
ETF Holders
327 ETFs hold DHR
25 shown · $18.80B total exposure · 0.29% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.19% | $4.4B | — | 2026-09-30 |
| 2 | VOO Vanguard S&P 500 ETF | Vanguard | 0.21% | $3.6B | — | 2026-09-30 |
| 3 | IVV iShares Core S&P 500 ETF | iShares (BlackRock) | 0.22% | $1.9B | $878.4B | 2026-10-21 |
| 4 | SPY State Street® SPDR® S&P 500® ETF Trust | SPDR (State Street) | 0.22% | $1.8B | $820.7B | 2026-10-21 |
| 5 | VTV Vanguard Morningstar Value ETF | Vanguard | 0.53% | $1.3B | — | 2026-09-30 |
| 6 | XLV State Street® Health Care Select Sector SPDR® ETF | SPDR (State Street) | 2.25% | $1.1B | $47.5B | 2026-10-21 |
| 7 | VIG Vanguard Dividend Appreciation ETF | Vanguard | 0.62% | $784.2M | — | 2026-09-30 |
| 8 | VHT Vanguard Health Care ETF | Vanguard | 1.97% | $431.3M | — | 2026-09-30 |
| 9 | SPYM State Street® SPDR® Portfolio S&P 500® ETF | SPDR (State Street) | 0.22% | $403.6M | $184.5B | 2026-10-21 |
| 10 | MOAT VanEck Morningstar Wide Moat ETF | VanEck | 2.87% | $335.7M | $11.9B | 2026-10-21 |
| 11 | IWD iShares Russell 1000 Value ETF | iShares (BlackRock) | 0.39% | $330.4M | $84.8B | 2026-10-21 |
| 12 | SCHG Schwab U.S. Large-Cap Growth ETF | Nport | 0.40% | $244.6M | — | 2026-05-31 |
| 13 | IVE iShares S&P 500 Value ETF | iShares (BlackRock) | 0.48% | $243.2M | $50.7B | 2026-10-21 |
| 14 | RSP Invesco S&P 500 Equal Weight ETF | Invesco | 0.23% | $224.1M | — | 2026-10-21 |
| 15 | EAGL Eagle Capital Select Equity ETF | Nport | 5.18% | $220.7M | — | 2026-06-30 |
| 16 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.20% | $190.0M | $96.2B | 2026-10-21 |
| 17 | SPYV State Street® SPDR® Portfolio S&P 500® Value ETF | SPDR (State Street) | 0.48% | $185.6M | $38.4B | 2026-10-21 |
| 18 | VV Vanguard Morningstar Large-Cap ETF | Vanguard | 0.22% | $165.1M | — | 2026-09-30 |
| 19 | IUSV iShares Core S&P U.S. Value ETF | iShares (BlackRock) | 0.46% | $129.2M | $28.4B | 2026-10-21 |
| 20 | SCHX Schwab U.S. Large-Cap ETF | Nport | 0.17% | $121.8M | — | 2026-05-31 |
| 21 | VT Vanguard Total World Stock ETF | Vanguard | 0.12% | $121.0M | — | 2026-09-30 |
| 22 | TCAF T. Rowe Price Capital Appreciation Equity ETF | Nport | 1.59% | $117.9M | — | 2026-06-30 |
| 23 | DGRO iShares Core Dividend Growth ETF | iShares (BlackRock) | 0.26% | $113.3M | $44.8B | 2026-10-21 |
| 24 | IWB iShares Russell 1000 ETF | iShares (BlackRock) | 0.21% | $101.9M | $48.6B | 2026-10-21 |
| 25 | NUDG Nuveen Dividend Growth Fund | Nport | 1.60% | $101.2M | — | 2026-07-31 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
37.73
TTM Diluted EPS
$6.11
TTM Revenue
$25.61B
TTM Net Income
$4.33B
TTM Op. Cash Flow
$6.86B
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q3 '26 | 2026-09-25 | $6.55B | $1.24B | $1.75 | $1.89B |
| Q2 '26 | 2026-06-26 | $6.26B | $870.00M | $1.23 | $1.53B |
| Q1 '26 | 2026-03-27 | $5.95B | $1.03B | $1.45 | $1.32B |
| Q4 '25 | 2025-12-31 | $6.84B | $1.20B | $1.68 | $2.12B |
| Q3 '25 | 2025-09-26 | $6.05B | $908.00M | $1.27 | $1.66B |
| Q2 '25 | 2025-06-27 | $5.94B | $555.00M | $0.77 | $1.34B |
| Q1 '25 | 2025-03-28 | $5.74B | $954.00M | $1.32 | $1.30B |
| Q4 '24 | 2024-12-31 | $6.54B | $1.09B | $1.49 | $2.02B |
| Q3 '24 | 2024-09-27 | $5.80B | $818.00M | $1.12 | $1.51B |
| Q2 '24 | 2024-06-28 | $5.74B | $907.00M | $1.22 | $1.42B |
| Q1 '24 | 2024-03-29 | $5.80B | $1.09B | $1.45 | $1.74B |
| Q4 '23 | 2023-12-31 | $6.41B | $1.08B | $1.44 | $1.62B |
Q3 2026 • period ending 2026-09-25 • filed 2026-10-21
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
40.94
P/B
3.12
P/S
6.54
EV/EBITDA
24.15
EV/Sales
7.37
ROE
7.6%
ROA
4.3%
Div Yield
0.63%
FCF Yield
4.04%
Debt/Equity
0.48
Current Ratio
—
Market Cap
$164.15B
as of 2026-10-23
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
8.97M
SI % of Float
1.43%
Days to Cover
1.76
Short Vol Ratio
44.6%
Free Float
626.43M
Float %
89.1%
Short interest 2026-09-30 • Short volume 2026-10-23 • Float 2026-08-24